SAM
IPSC icon

Smartleaf Asset Management’s Century Therapeutics IPSC Stock Holding History

Smartleaf Asset Management’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2 Hold
1
– – ﹤0.01% 3459
2026
Q1 		$2 Hold
1
– – ﹤0.01% 3502
2025
Q4 		$1 Buy
+1
New +$1 ﹤0.01% 3488
2024
Q4 		– Sell
-1,609
Closed -$2.59K – 2964
2024
Q3 		$2.59K Buy
+1,609
New +$3.15K ﹤0.01% 2395

Other funds holding IPSC

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Smartleaf Asset Management's IPSC Position: Q2 2026 in Review

Smartleaf Asset Management held its Century Therapeutics (IPSC) position steady in Q2 2026 at 1 share worth $2. The position accounts for ﹤0.01% of the portfolio, ranked #3459.

Smartleaf Asset Management first reported a position in IPSC in Q3 2024 and has held it in 4 quarters since. The position peaked at $2.59K in Q3 2024. 99 funds tracked by Wall St. Rank hold IPSC as of Q2 2026.

  • Smartleaf Asset Management held 1 share of Century Therapeutics worth $2 as of Q2 2026.
  • Smartleaf Asset Management left its Century Therapeutics share count unchanged in Q2 2026.
  • Century Therapeutics made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #3459 holding.
  • Smartleaf Asset Management first reported a position in Century Therapeutics in Q3 2024 and has held it in 4 quarters since.
  • Smartleaf Asset Management's Century Therapeutics position peaked at $2.59K in Q3 2024.
  • 99 funds tracked by Wall St. Rank held Century Therapeutics as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.